LUMO - Lumos Pharma - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

LUMO is currently covered by 2 analysts with an average price target of $-4.85. This is a potential upside of $-9.19 (-211.75%) from yesterday's end of day stock price of $4.34.

Lumos Pharma's activity chart (see below) currently has 39 price targets and 42 ratings on display. The stock rating distribution of LUMO is 100% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 66.82% with an average time for these price targets to be met of 359.45 days.

Highest price target for LUMO is $4.25, Lowest price target is $4.25, average price target is $4.25.

Most recent stock forecast was given by EDWARD WHITE from HCWAINWRIGHT on 07-Nov-2024. First documented stock forecast 09-May-2016.

Currently out of the existing stock ratings of LUMO, 3 are a HOLD (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

$4.25

$-0.09 (-2.07%)

$4.25

11 months 16 days ago
(07-Nov-2024)

1/5 (20%)

$-0.11 (-2.52%)

148

Buy

1 years 10 months 14 days ago
(10-Dec-2023)

0/1 (0%)

$12.65 (172.11%)

Buy

$10

$5.66 (130.41%)

$10

2 years 2 months 2 days ago
(21-Aug-2023)

1/4 (25%)

$7.03 (236.70%)

28

Hold

$7

$2.66 (61.29%)

$7

2 years 10 months 16 days ago
(07-Dec-2022)

2/4 (50%)

$2.8 (66.67%)

79

Buy

$26

2 years 11 months 10 days ago
(13-Nov-2022)

2/5 (40%)

$17.95 (222.98%)

182

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is LUMO (Lumos Pharma) average time for price targets to be met?

On average it took 359.45 days on average for the stock forecasts to be realized with a an average price target met ratio 66.82

Which analyst has the current highest performing score on LUMO (Lumos Pharma) with a proven track record?

PETER LAWSON

Which analyst has the most public recommendations on LUMO (Lumos Pharma)?

Peter Lawson works at BARCLAYS and has 7 price targets and 4 ratings on LUMO

Which analyst is the currently most bullish on LUMO (Lumos Pharma)?

Peter Lawson with highest potential upside - $15.55

Which analyst is the currently most reserved on LUMO (Lumos Pharma)?

Michael Ulz with lowest potential downside - -$0.34

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?